Endometrial Lymphangiogensis

Placenta

Volumn 29, Issue SUPPL., 2008, Pages 48-54

  Rogers, P A W ^a   Donoghue, J F ^a   Girling, J E ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

Endometrium; Lymphangiogenesis; Vascular endothelial growth factor (VEGF) C; VEGF D; VEGF R3

Indexed keywords

HOMEODOMAIN PROTEIN; PODOPLANIN; PROTEIN PROX1; UNCLASSIFIED DRUG; VASCULOTROPIN C; VASCULOTROPIN D; VASCULOTROPIN RECEPTOR 3;

ARTICLE; ENDOMETRIAL DISEASE; ENDOMETRIAL LYMPHANGIOGENSIS; HISTOPATHOLOGY; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; ENDOMETRIUM; FEMALE; HUMANS; LYMPHANGIOGENESIS; LYMPHATIC SYSTEM; PREGNANCY;

EID: 40849102962     PISSN: 01434004     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.placenta.2007.09.009     Document Type: Article

References (39)

1. Kaipainen A., Korhonen J., Mustonen T., van Hinsbergh V., Fang G.-H., Dumont D., et al. Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development. Proc Natl Acad Sci USA 92 (1995) 3566-3570
2. Banerji S., Ni J., Wang S.-X., Clasper S., Su J., Tammi R., et al. Lyve-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan. J Cell Biol 144 (1999) 89-801
3. Breiteneder-Geleff S., Soleiman A., Kowalski H., Horvat R., Amann G., Kriehuber E., et al. Angiosarcomas express mixed endothelial phenotypes of blood and lymphatic capillaries. Am J Pathol 154 (1999) 385-394
4. Wigle J.T., and Oliver G. Prox1 function is required for the development of the murine lymphatic system. Cell 98 (1999) 769-778
5. Adams R.H., and Alitalo K. Molecular regulation of angiogenesis and lymphangiogenesis. Nat Rev Mol Cell Biol 8 (2007) 464-478
6. Jeltsch M., Kaipainen A., Joukov V., Meng X., Lakso M., Rauvala H., et al. Hyperplasia of lymphatic vessels in VEGF-C transgenic mice. Science 276 (1997) 1423-1425
7. Stacker S., Caesar C., Baldwin M., Thornton G., Williams R., Prevo R., et al. VEGF-D promotes the metastatic spread of tumor cells via the lymphatics. Nature 7 (2001) 186-191
8. Veikkola T., Jussila L., Makinen T., Karpanen T., Jeltsch M., Petrova T., et al. Signaling via vascular endothelial growth factor receptor-3 is sufficient for lymphangiogenesis in transgenic mice. EMBO J 20 (2001) 1223-1231
9. Stacker S., Stenvers K., Caesar C., Vitali A., Domagala T., Nice E., et al. Biosynthesis of vascular endothelial growth factor-D involves proteolytic processing which generates non-covalent homodimers. J Biol Chem 274 (1999) 32127-32136
10. Joukov V., Sorsa T., Kumar V., Jeltsch M., Claesson-Welsh L., Cao Y., et al. Proteolytic processing regulates receptor specificity and activity of VEGF-C. EMBO J 16 (1997) 3898-3911
11. Karkkainen M.J., Haiko P., Sainio K., Partanen J., Taipale J., Petrova T.V., et al. Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins. Nat Immunol 5 (2004) 74-80
12. Alitalo K., Tammela T., and Petrova T.V. Lymphangiogenesis in development and human disease. Nature 438 (2005) 946-953
13. Tammela T., Enholm B., Alitalo K., and Paavonen K. The biology of vascular endothelial growth factors. Cardiovas Res 65 (2005) 550-563
14. Ober E.A., Olofsson B., Mäkinen T., Jin S.W., Shoji W., Koh G.Y., et al. Vegfc is required for vascular development and endoderm morphogenesis in zebrafish. EMBO Rep 5 (2004) 78-84
15. Dumont D.J., Jussila L., Taipale J., Lymboussaki A., Mustonen T., Pajusola K., et al. Cardiovascular failure in mouse embryos deficient in VEGF receptor-3. Science 282 (1998) 946-949
16. Karpanen T., Wirzenius M., Mäkinen T., Veikkola T., Haisma H.J., Achen M.G., et al. Lymphangiogenic growth factor responsiveness is modulated by postnatal lymphatic vessel maturation. Am J Pathol 169 (2006) 708-718
17. Mäkinen T., Jussila L., Veikkola T., Karpanen T., Kettunen M.I., Pulkkanen K.J., et al. Inhibition of lymphangiogenesis with resulting lymphedema in transgenic mice expressing soluble VEGF receptor-3. Nat Med 7 (2001) 199-205
18. Laakkonen P., Waltari M., Holopainen T., Takahashi T., Pytowski B., Steiner P., et al. Vascular endothelial growth factor receptor 3 is involved in tumor angiogenesis and growth. Cancer Res 67 (2007) 593-599
19. Yuan L., Moyon D., Pardanaud L., Bréant C., Karkkainen M.J., Alitalo K., et al. Abnormal lymphatic vessel development in neuropilin 2 mutant mice. Development 129 (2002) 4797-4806
20. Kärpänen T., Heckman C.A., Keskitalo S., Jeltsch M., Ollila H., Neufeld G., et al. Functional interaction of VEGF-C and VEGF-D with neuropilin receptors. FASEB J 20 (2006) 1462-1472
21. Vlahakis N.E., Young B.A., Atakilit A., Hawkridge A.E., Issaka R.B., Boudreau N., et al. Integrin α9β1 directly binds to vascular endothelial growth factor (VEGF)-A and contributes to VEGF-A-induced angiogenesis. J Biol Chem 282 (2007) 15187-15196
22. Nagy J.A., Vasile E., Feng D., Sundberg C., Brown L.F., Detmar M.J., et al. Vascular permeability factor/vascular endothelial growth factor induces lymphangiogenesis as well as angiogenesis. J Exp Med 196 (2002) 1497-1506
23. Cursiefen C., Chen L., Borges L.P., Jackson D., Cao J., Radziejewski C., et al. VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment. J Clin Invest 113 (2004) 1040-1050
24. Gale N.W., Thurston G., Hackett S.F., Renard R., Wang Q., McClain J., et al. Angiopoietin-2 is required for postnatal angiogenesis and lymphatic patterning, and only the latter role is rescued by Angiopoietin-1. Dev Cell 3 (2002) 411-423
25. Tammela T., Saaristo A., Lohela M., Morisada T., Tornberg J., Norrmén C., et al. Angiopoietin-1 promotes lymphatic sprouting and hyperplasia. Blood 105 (2005) 4642-4648
26. Mäkinen T., Adams R.H., Bailey J., Lu Q., Ziemiecki A., Alitalo K., et al. PDZ interaction site in ephrinB2 is required for the remodeling of lymphatic vasculature. Genes Dev 19 (2005) 397-410
27. Foo S.S., Turner C.J., Adams S., Compagni A., Aubyn D., Kogata N., et al. Ephrin-B2 controls cell motility and adhesion during blood-vessel-wall assembly. Cell 124 (2006) 161-173
28. Petrova T.V., Karpanen T., Norrmén C., Mellor R., Tamakoshi T., Finegold D., et al. Defective valves and abnormal mural cell recruitment underlie lymphatic vascular failure in lymphedema distichiasis. Nat Med 10 (2004) 974-981
29. Donoghue J.F., Lederman F.L., Susil B.J., and Rogers P.A. Lymphangiogenesis of normal endometrium and endometrial adenocarcinoma. Hum Reprod 22 (2007) 1705-1713
30. Red-Horse K., Rivera J., Schanz A., Zhou Y., Winn V., Kapidzic M., et al. Cytotrophoblast induction of arterial apoptosis and lymphangiogenesis in an in vivo model of human placentation. J Clin Invest 116 (2006) 2643-2652
31. Koukourakis M., Giatromanolaki A., Sivridis E., Simopoulos C., Gatter K., Harris A., et al. LYVE-1 immunohistochemical assessment of lymphangiogenesis in endometrial and lung cancer. J Clin Pathol 58 (2005) 202-206
32. Ueki M. Histologic study of endometriosis and examination of lymphatic drainage in and from the uterus. J Obstet Gynecol 165 (1991) 201-209
33. Uchino S., Ichikawa S., Okubo M., Nakamura Y., and Iimura A. Methods of detection of lymphatics and their changes with oestrous cycle. Inter Angio 6 (1987) 271-278
34. Blackwell P., and Fraser I. Superficial lymphatics in the functional zone of normal human endometrium. Microvasc Res 21 (1981) 142-152
35. Schacht V., Dadras S., Johnson L., Jackson D., Kong Y.-K., and Detmar M. Up-regulation of the lymphatic marker podoplanin, a mucin-type transmembrane glycoprotein, in human squamous cell carcinomas and germ cell tumors. Am J Pathol 166 (2005) 913-921
36. Noyes R.W., Hertig A.T., and Rock J. Dating the endometrial biopsy. Fertil Steril 1 (1950) 3-25
37. Möller B., Lindbolm B., and Olovsson M. Expression of the vascular endothelial growth factors B and C and their receptors in human endometrium during the menstrual cycle. Acta Obstet Gynecol Scand 81 (2002) 817-824
38. Mints M., Blomgren B., Falconer C., and Palmblad J. Expression of the vascular endothelial growth factor (VEGF) family in human endometrial blood vessels. Scand J Clin Lab Invest 62 (2002) 167-176
39. Yokoyama Y., Charnock-Jones D.S., Licence D., Yanaihara A., Hastings J., Holland C., et al. Vascular endothelial growth factor-D is an independent prognostic factor in epithelial ovarian carcinoma. Br J Cancer 27 (2003) 237-244